IKT Competitors & Alternatives
Compare Inhibikase Therapeutics Inc with similar stocks in the same industry
Biotechnology
IKT
Main Stock$2.34
Tradestie Score
46
Market Cap
$119.97M
Revenue Growth
-1.0%
Analyst Upside
+157.0%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$19.85
|
$354.45M | - | 41 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$43.62
|
$353.70M | - | 43 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.81
|
$350.98M | - | 48 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.25
|
$341.56M | - | 39 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.88
|
$332.96M | - | 42 | Compare |
|
REPL
Replimune Group, Inc.
|
$12.82
|
$328.62M | - | 44 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$13.35
|
$308.74M | - | 46 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$8.02
|
$307.12M | - | 35 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.56
|
$304.12M | - | 45 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$17.62
|
$297.23M | - | 43 | Compare |
More IKT Analysis
Data updated: Sep 15, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry